SHANGHAI, March 13, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has been...
Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025 )
Also on site :
- Couple Bring Cat To Vet, Realize Something Heartbreaking Once They Arrive
- Ukrainian teachers told to pretend they can’t speak Russian
- Asking Eric: New friend’s cooking turns the stomach